| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium adolescentis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium breve co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium longum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium ruminatum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium ruminatum co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Collinsella intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Eggerthella lenta co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [6] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [8] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [10], [11] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [13], [10] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Alistipes indistinctus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Alistipes indistinctus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides cellulosilyticus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides coprophilus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [17] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides dorei co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides eggerthii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides eggerthii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides eggerthii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides finegoldii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides fragilis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides ovatus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides sartorii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides stercoris co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides stercoris co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides thetaiotaomicron co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Irinotecan hydrochloride, and Bacteroides thetaiotaomicron further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [21] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides thetaiotaomicron co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides uniformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Irinotecan hydrochloride, and Bacteroides uniformis further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [21] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides xylanisolvens co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Odoribacter splanchnicus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Odoribacter splanchnicus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Odoribacter splanchnicus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides distasonis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides johnsonii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides merdae co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Prevotella copri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Anaerobutyricum hallii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Anaerococcus hydrogenalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Anaerostipes hadrus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Anaerotruncus colihominis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [23] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [24] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [25], [26] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides pectinophilus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia hansenii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Blautia luti co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridioides difficile co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium botulinum co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Irinotecan hydrochloride, and Clostridium perfringens further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [28] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium scindens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium spiroforme co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium sporogenes co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium sporogenes co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Clostridium symbiosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Coprococcus comes co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Dorea formicigenerans co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterocloster asparagiformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterocloster bolteae co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterococcus faecalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Erysipelatoclostridium ramosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Eubacterium rectale co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Eubacterium ventriosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [17] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Holdemanella biformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Holdemanella biformis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Hungatella hathewayi co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Lactobacillus reuteri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [17] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Marvinbryantia formatexigens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Roseburia intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Roseburia intestinalis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Ruminococcus gnavus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [17] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Ruminococcus lactaris co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Ruminococcus torques co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Streptococcus agalactiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Irinotecan hydrochloride, and Streptococcus agalactiae further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [28] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Subdoligranulum variabile co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Victivallis vadensis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Proteobacteria |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Edwardsiella tarda co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterobacter cancerogenus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| AN-16649 |
Click to Show/Hide the Detail |
| Drug ID |
DR0173
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug AN-16649, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [30] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Flunitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0712
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [32] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) metabolizes the drug Irinotecan hydrochloride, and Escherichia coli further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [33] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Irinotecan hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [33] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [34] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Escherichia coli co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Proteus penneri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Providencia alcalifaciens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Providencia rettgeri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Providencia rettgeri co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Providencia stuartii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [36] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Salmonella enterica co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Akkermansia muciniphila co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Archaea: Euryarchaeota |
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [37] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [37] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [37] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2B6 (CYP2B6) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [37] |
|
|
|
|
|
|